{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:30:23Z","timestamp":1761514223266,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T00:00:00Z","timestamp":1529280000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000145","name":"Alberta Innovates - Health Solutions","doi-asserted-by":"publisher","award":["10004299"],"award-info":[{"award-number":["10004299"]}],"id":[{"id":"10.13039\/501100000145","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13063-018-2720-6","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T07:31:43Z","timestamp":1529307103000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma"],"prefix":"10.1186","volume":"19","author":[{"given":"Veronica","family":"Swystun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9768-9366","authenticated-orcid":false,"given":"Francis H. Y.","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Dennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanouil","family":"Rampakakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurkeet","family":"Lalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morenike","family":"Fadayomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grishma","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharif Galal","family":"El Shahat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Evan","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamer Y.","family":"El Mays","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cora A.","family":"Pieron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Leigh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,18]]},"reference":[{"key":"2720_CR1","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1183\/13993003.00853-2015","volume":"46","author":"HK Reddel","year":"2015","unstructured":"Reddel HK, Bateman ED, Becker A, Boulet LP, Cruz AA, Drazen JM, et al. A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J. 2015;46:622\u201339.","journal-title":"Eur Respir J"},{"key":"2720_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1097\/MCC.0b013e328348bf09","volume":"17","author":"BH Rowe","year":"2011","unstructured":"Rowe BH, Sevcik W, Villa-Roel C. Management of severe acute asthma in the emergency department. Curr Opin Crit Care. 2011;17:335\u201341.","journal-title":"Curr Opin Crit Care"},{"key":"2720_CR3","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJM199210223271703","volume":"327","author":"D Cheung","year":"1992","unstructured":"Cheung D, Timmers MC, Zwinderman AH, Bel EH, Dijkman JH, Sterk PJ. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma. N Engl J Med. 1992;327:1198\u2013203.","journal-title":"N Engl J Med"},{"key":"2720_CR4","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1056\/NEJM199210223271704","volume":"327","author":"BJ O\u2019Connor","year":"1992","unstructured":"O\u2019Connor BJ, Aikman SL, Barnes PJ. Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma. N Engl J Med. 1992;327:1204\u20138.","journal-title":"N Engl J Med"},{"key":"2720_CR5","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/0140-6736(93)92695-P","volume":"342","author":"DW Cockcroft","year":"1993","unstructured":"Cockcroft DW, McParland CP, Britto SA, Swystun VA, Rutherford BC. Regular inhaled salbutamol and airway responsiveness to allergen. Lancet. 1993;342:833\u20137.","journal-title":"Lancet"},{"key":"2720_CR6","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1183\/09059180.00001913","volume":"22","author":"RR Wener","year":"2013","unstructured":"Wener RR, Bel EH. Severe refractory asthma: an update. Eur Respir Rev. 2013;22:227\u201335.","journal-title":"Eur Respir Rev"},{"key":"2720_CR7","first-page":"A5997","volume":"191","author":"MR Al-Saiedy","year":"2015","unstructured":"Al-Saiedy MR, Nelson DE, Amrein M, Leigh R, Green F. The role of an artificial surfactant in mucous plug clearance in vitro. Am J Respir Crit Care Med. 2015;191:A5997.","journal-title":"Am J Respir Crit Care Med"},{"key":"2720_CR8","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.prrv.2005.03.010","volume":"6","author":"MR Wolfson","year":"2005","unstructured":"Wolfson MR, Shaffer TH. Pulmonary applications of perfluorochemical liquids: ventilation and beyond. Paediatr Respir Rev. 2005;6:117\u201327.","journal-title":"Paediatr Respir Rev"},{"key":"2720_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1081\/BIO-200046659","volume":"33","author":"JG Riess","year":"2005","unstructured":"Riess JG. Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery. Artif Cells Blood Substit Immobil Biotechnol. 2005;33:47\u201363.","journal-title":"Artif Cells Blood Substit Immobil Biotechnol"},{"key":"2720_CR10","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1097\/01.CCM.0000124876.31138.F6","volume":"32","author":"K von der Hardt","year":"2004","unstructured":"von der Hardt K, Kandler MA, Brenn G, Scheuerer K, Schoof E, Dotsch J, Rascher W. Comparison of aerosol therapy with different perfluorocarbons in surfactant-depleted animals. Crit Care Med. 2004;32:1200\u20136.","journal-title":"Crit Care Med"},{"key":"2720_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1164\/ajrccm.164.1.2010049","volume":"164","author":"MA Kandler","year":"2001","unstructured":"Kandler MA, von der Hardt K, Schoof E, Dotsch J, Rascher W. Persistent improvement of gas exchange and lung mechanics by aerosolized perfluorocarbon. Am J Respir Crit Care Med. 2001;164:31\u20135.","journal-title":"Am J Respir Crit Care Med"},{"key":"2720_CR12","first-page":"861","volume":"114","author":"HK Fisher","year":"1976","unstructured":"Fisher HK, Hansen TA. Site of action of inhaled 6 per cent carbon-dioxide in lungs of asthmatic subjects before and after exercise. Am Rev Respir Dis. 1976;114:861\u201370.","journal-title":"Am Rev Respir Dis"},{"key":"2720_CR13","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1139\/y11-052","volume":"89","author":"TY El Mays","year":"2011","unstructured":"El Mays TY, Saifeddine M, Choudhury P, Hollenberg MD, Green FH. Carbon dioxide enhances substance P-induced epithelium-dependent bronchial smooth muscle relaxation in Sprague-Dawley rats. Can J Physiol Pharmacol. 2011;89:513\u201320.","journal-title":"Can J Physiol Pharmacol"},{"key":"2720_CR14","first-page":"A2848","volume":"185","author":"T El Mays","year":"2012","unstructured":"El Mays T, Snibson K, Wilson R, Leigh R, Dennis J, Nelson D, Green F, Choudhury P. Investigations of mechanisms of carbon dioxide-induced bronchial smooth muscle relaxation. Am J Respir Crit Care Med. 2012;185:A2848.","journal-title":"Am J Respir Crit Care Med"},{"key":"2720_CR15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12931-014-0098-x","volume":"15","author":"TY El Mays","year":"2014","unstructured":"El Mays TY, Choudhury P, Leigh R, Koumoundouros E, Van der Velden J, Shrestha G, Pieron CA, Dennis JH, Green FH, Snibson KJ. Nebulized perflubron and carbon dioxide rapidly dilate constricted airways in an ovine model of allergic asthma. Respir Res. 2014;15:98.","journal-title":"Respir Res"},{"key":"2720_CR16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s13063-016-1489-8","volume":"17","author":"FH Green","year":"2016","unstructured":"Green FH, Leigh R, Fadayomi M, Lalli G, Chiu A, Shrestha G, ElShahat SG, Nelson DE, El Mays TY, Pieron CA, Dennis JH. A phase I, placebo-controlled, randomized, double-blind, single ascending dose-ranging study to evaluate the safety and tolerability of a novel biophysical bronchodilator (S-1226) administered by nebulization in healthy volunteers. Trials. 2016;17:361.","journal-title":"Trials"},{"key":"2720_CR17","first-page":"A5788","volume":"191","author":"F Green","year":"2015","unstructured":"Green F, Leigh R, Shrestha G, Galal S, Chiu A, Fadayomi M, Pieron C, El Mays T, Nelson DE, Al-Saiedy MR, et al. Development of a new bronchodilator to enable better treatment of asthma, COPD, and CF. Am J Respir Crit Care Med. 2015;191:A5788.","journal-title":"Am J Respir Crit Care Med"},{"key":"2720_CR18","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jaci.2013.08.023","volume":"132","author":"Z Diamant","year":"2013","unstructured":"Diamant Z, Gauvreau GM, Cockcroft DW, Boulet LP, Sterk PJ, de Jongh FH, Dahlen B, O\u2019Byrne PM. Inhaled allergen bronchoprovocation tests. J Allergy Clin Immunol. 2013;132:1045\u201355. e1046","journal-title":"J Allergy Clin Immunol"},{"key":"2720_CR19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1152\/ajplegacy.1947.149.1.43","volume":"149","author":"RD Dripps","year":"1947","unstructured":"Dripps RD, Comroe JH Jr. The respiratory and circulatory response of normal man to inhalation of 7.6 and 10.4 per cent CO2 with a comparison of the maximal ventilation produced by severe muscular exercise, inhalation of CO2 and maximal voluntary hyperventilation. Am J Phys. 1947;149:43\u201351.","journal-title":"Am J Phys"},{"key":"2720_CR20","first-page":"41","volume":"68","author":"CM Maresh","year":"1997","unstructured":"Maresh CM, Armstrong LE, Kavouras SA, Allen GJ, Casa DJ, Whittlesey M, LaGasse KE. Physiological and psychological effects associated with high carbon dioxide levels in healthy men. Aviat Space Environ Med. 1997;68:41\u20135.","journal-title":"Aviat Space Environ Med"},{"key":"2720_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jaci.2007.08.056","volume":"121","author":"TB Casale","year":"2008","unstructured":"Casale TB, Romero FA, Spierings EL. Intranasal noninhaled carbon dioxide for the symptomatic treatment of seasonal allergic rhinitis. J Allergy Clin Immunol. 2008;121:105\u20139.","journal-title":"J Allergy Clin Immunol"},{"key":"2720_CR22","first-page":"686","volume":"42","author":"M Al-Saiedy","year":"2013","unstructured":"Al-Saiedy M, Nelson E, El-Mays T, Amrein M, Green F. Perflubron enhances mucin plug clearance in vitro in the presence of natural surfactant. Euro Respir J. 2013;42:686.","journal-title":"Euro Respir J"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2720-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-018-2720-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2720-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T19:27:51Z","timestamp":1560799671000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-018-2720-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,18]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2720"],"URL":"https:\/\/doi.org\/10.1186\/s13063-018-2720-6","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2018,6,18]]},"assertion":[{"value":"21 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted at the Respiratory Clinical Trials Centre, University of Calgary, AB, Canada. All procedures were conducted in accordance with the standard operating procedures for the Respiratory Clinical Trials Centre. The study is registered with  (). The study follows the Consolidated Standards of Reporting Trials (CONSORT) 2010 checklist (see Additional\u00a0file\u00a0).This study was conducted in accordance with the Declaration of Helsinki. The Conjoint Health Research Ethics Board of the University of Calgary approved the study protocol, amendments, and consent form (REB14\u20131581). Written informed consent was obtained from all subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"FHYG and JHD are founders, shareholders, management, and board members of SolAeroMed Inc., a biotechnology company with patent rights for S1226. GL, MF, AC, TYEM, CAP, and RL are shareholders in SolAeroMed Inc. VS, ER, GS, SG, and DEN have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"321"}}